Drugs company Sequella and the University of Maryland in Baltimore are
patenting a system to help fight tuberculosis (W0 00/37114). The WHO warns that
TB bacteria are becoming resistant to antibiotics because patients do not finish
the course of treatment. The new process mixes the drug with a fluorescent
dye鈥攆luorescein, indocyanin green or rhodamine. This causes a slight
fluorescence when the skin is illuminated. Patients wear a bracelet which shines
light at the skin. A sensor signals 鈥淥K鈥� on a small display if it detects
fluorescence. Doctors only have to glance at it to know if a patient has taken
the drug.
More from New Scientist
Explore the latest news, articles and features
Technology
Google shouldn鈥檛 be pressuring schools to use its AI
91色情片
Technology
Australia鈥檚 social media ban faces high court challenge
News
Technology
The nuclear waste repository in Finland designed to outlast modern civilisation
Features
Technology
How did the biggest crypto heist in history just happen?
News
Popular articles
Trending New Scientist articles